Canon Kabushiki Kaisha

Daiichi Sankyo Company, Limited

Nissan Motor Company Limited

Kato Hatsujo Kaisha, Ltd.

Mitsubishi Heavy Industries Limited

Amgen Inc.

Yasuyuki Ogawa

Keiji Saito

Osamu Iwamoto

Katsuyoshi Nakajima

Kaori Ito

Kazumasa Aoki

Toru Taniguchi

Nobuya Kurikawa

Eriko Kioi

Satoshi Shibuya

Shinji Tanaka

Momoko Ogitani

Natsumi Nishihama

Wataru Saitoh

Tsuyoshi Mikkaichi

Yuichi Nakase

Hitoshi Watanabe

Satoshi Asada

Seiko Nagata

Akira Suga

Makoto Gohda

Tsuneaki Kadosawa

Takashi Nakamura

Hiroyuki Ogino

Koji Sudo

Nobukazu Yoshida

Hidenori Takahashi

Chiyumi Niwa

Mikio Kato

Yoshikazu Uto

Hiroko Kono

Mitsuhiro Makino

Makoto Hirasawa

Hiroshi Kondo

Yuji Nakamura

Toshio Sato

Takashi Aizawa

Takashi Sonoda

Kuniaki Aoyama

Ming Yu

Zice Fu

Xiaolin Hao

Leping Li

Satoshi Ogiwara

Hui Tian

Sarah Lively

Zhaodan Cao

Masashi Yoshida

Mike Elias Lizarzaburu

Narihiro Toda

Takahiro Nagayama

Shojiro Miyazaki

Yousuke Takagi

Masahiko Morita

Kouichi Yaotani

Daisuke Kudo

Yong-Jae Kim

Shunsaku Matsumoto

Taro Tokui

Mika Tsukuda

Megumi Yoshino

Ryo Okuyama

Sarah E Lively

Iwamoto,osamu

Mike Lizarzaburu

A cause estimation device includes: an acquisition unit that acquires a measurement value of a target apparatus; a likelihood calculation unit that calculates, in a case where it is assumed that events occur due to a common cause, a likelihood of an occurrence of each of the events based on the measurement value; a table storage unit that stores a cause table in which a cause of occurrence of the event and a frequency of the cause of occurrence are associated with each other for each of the plurality of events; and an estimation unit that rewrites the frequency registered in the cause table into a frequency in the case where it is assumed that the plurality of events occur due to the common cause, and estimates the cause of occurrence based on the rewritten cause table and the likelihood.

Cause estimation apparatus and cause estimation method

An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: A: e.g., Benzene, E: e.g., —CH—, G: e.g., a 5-membered aromatic heterocyclic ring, X: e.g., cyclohexane, J: e.g., a 5-membered aromatic heterocyclic ring, Y: e.g., a phenyl group, R, R, R: e.g., a halogen atom, R: e.g., a C1-C6 alkyl group, R: e.g., a hydrogen atom, R, R, R, R: e.g., a hydrogen atom, R: e.g., a hydrogen atom, R: e.g., a hydrogen atom, n, n, n: e.g., 1.

Compound having cyclic structure

An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below: R: e.g., a C1-C6 alkyl group; R: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R: e.g., a C1-C6 alkyl group.

Griseofulvin compound

The present invention addresses the problem of providing a compound for prophylaxis and/or treatment of central inflammatory diseases, or a pharmacologically acceptable salt thereof. The present invention addresses a compound of a general formula (I) or a pharmacologically acceptable salt thereof as a means to solve the problem. [R: a C1-C6 alkyl group or the like, R: a C1-C6 alkyl group or the like, A: a 5-membered aromatic hetero-ring or the like, R, R': a C1-C6 alkyl group or the like].

Griseofulvin compound and pharmaceutical use thereof

An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below:R: e.g., a C1-C6 alkyl group; R: a C1-C6 alkyl group;A: e.g., an oxygen atom; and R: e.g., a C1-C6 alkyl group.

An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof. The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof. wherein the symbols in the formula are defined below:A: e.g., Benzene, E: e.g., &#x2014;CH&#x2014;, G: e.g., a 5-membered aromatic heterocyclic ring, X: e.g., cyclohexane, J: e.g., a 5-membered aromatic heterocyclic ring, Y: e.g., a phenyl group, R, R, R: e.g., a halogen atom, R: e.g., a C1-C6 alkyl group, R: e.g., a hydrogen atom, R, R, R, R: e.g., a hydrogen atom, R: e.g., a hydrogen atom, R: e.g., a hydrogen atom, n, n, n: e.g., 1.

The present invention addresses the problem of providing a compound for prophylaxis and/or treatment of central inflammatory diseases, or a pharmacologically acceptable salt thereof. The present invention addresses a compound of a general formula (I) or a pharmacologically acceptable salt thereof as a means to solve the problem. [R: a C1-C6 alkyl group or the like, R: a C1-C6 alkyl group or the like, A: a 5-membered aromatic hetero-ring or the like, R, R: a C1-C6 alkyl group or the like.

It is an object of the present invention to provide a medicament for preventing or treating hyperphosphatemia. Solution: A compound represented by a general formula (I) or a pharmacologically acceptable salt thereof. (In the formula, R: a methyl group or the like, R: a hydrogen atom or the like, R: a hydrogen atom or the like, A: a cyclohexyl ring or the like, X: CH or the like, Y: CH or the like, Z: CH or the like, and n: 2 or the like).

Dicarboxylic acid compound

It is an object of the present invention to provide a medicament for preventing or treating hyperphosphatemia. Solution: A compound represented by a general formula (I) or a pharmacologically acceptable salt thereof. [In the formula, R: a methyl group or the like, R: a hydrogen atom or the like, R: a hydrogen atom or the like, A: a cyclohexyl ring or the like, X: CH or the like, Y: CH or the like, Z: CH or the like, and n: 2 or the like].

A recording medium removable from a host device includes a wireless communication unit for performing wireless communication with an external device different from the host device. The recording medium includes an image transmission control unit which transmits image data to the external device via the wireless communication established by the wireless communication unit by using an image transmission protocol. The recording medium switches which of the image transmission control unit of the recording medium and an image transmission control unit of the host device is used to communicate with the external device via the wireless communication unit.

Recording medium and control method thereof

A system, method and computer program product for arranging digital data in a file in an apparatus-implemented system, is disclosed. One or more pages are generated, where each page includes: i. a mode field containing a camera operation mode, ii. an image data field containing image data, iii. an offset field containing an offset to a next page in the file, and a total size field containing a page size. Each page is recorded in the file using the same format.

Image recording apparatus, image reproducing apparatus, method of controlling image recording apparatus, method of controlling image reproducing apparatus, computer program, and recording medium, with storing of a plurality of frame images, a plurality of attribute information in EXIF format, and plurality of offset data in one image file

Growing community of inventors

Tokyo, Japan

Yasuyuki Ogawa